Vaccine News and Research

Latest Vaccine News and Research

Mesoporous silica nanoparticles: Possibilities in therapeutic development

Mesoporous silica nanoparticles: Possibilities in therapeutic development

New COVID vaccine patch could better fight variants than a traditional needle, finds study

New COVID vaccine patch could better fight variants than a traditional needle, finds study

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

The nose key to winning the war against COVID-19

The nose key to winning the war against COVID-19

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

India, Pakistan tackle backslide in child immunizations

India, Pakistan tackle backslide in child immunizations

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Innovative technology reveals new insights into cellular reservoirs of HIV

Innovative technology reveals new insights into cellular reservoirs of HIV

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

SARS-CoV-2 Omicron BA.5 neutralization in vaccinated individuals

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

Study estimates prevalence of SARS-CoV-2 omicron breakthrough infections in South Africa

To stem the spread of monkeypox, health departments tap into networks of those most at risk

To stem the spread of monkeypox, health departments tap into networks of those most at risk

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Study confirms link between Epstein-Barr virus and multiple sclerosis

Study confirms link between Epstein-Barr virus and multiple sclerosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.